{
    "N/R/U": null,
    "Applicant": "CSL Behring AG",
    "BLA Number": "125350",
    "Proprietary Name": "Hizentra",
    "Proper Name": "Immune Globulin Subcutaneous (Human), 20% Liquid",
    "BLA Type": "351(a)",
    "Strength": "10G/50ML",
    "Dosage Form": "Injection",
    "Route of Administration": "Subcutaneous",
    "Product Presentation": "Pre-Filled Syringe",
    "Marketing Status": "Rx",
    "Licensure": "Licensed",
    "Approval Date": "April 13, 2023",
    "Ref. Product Proper Name": " ",
    "Ref. Product Proprietary Name": null,
    "Supplement Number": "1217",
    "Submission Type": "Supplement",
    "License Number": "1766",
    "Product Number": "005",
    "Center": "CBER",
    "Date of First Licensure": null,
    "Exclusivity Expiration Date": null,
    "First Interchangeable Exclusivity Exp. Date": null,
    "Ref. Product Exclusivity Exp. Date": null,
    "Orphan Exclusivity Exp. Date": "March 15, 2025"
}